- Report
- June 2018
- 155 Pages
Global
From €601EUR$625USD£515GBP
€1201EUR$1,250USD£1,030GBP
- Report
- March 2018
- 172 Pages
Global
From €1322EUR$1,375USD£1,133GBP
€2643EUR$2,750USD£2,267GBP
- Report
- July 2022
- 110 Pages
United States
From €5719EUR$5,950USD£4,904GBP
- Report
- March 2022
- 300 Pages
Global
From €3845EUR$4,000USD£3,297GBP
- Report
- September 2019
- 76 Pages
South Africa
From €2018EUR$2,100USD£1,731GBP
€2883EUR$3,000USD£2,473GBP
- Report
- June 2022
- 120 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- August 2022
- 117 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- January 2022
- 60 Pages
Global
From €3797EUR$3,950USD£3,256GBP
- Report
- September 2022
- 113 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- March 2018
Global
From €4325EUR$4,500USD£3,709GBP
- Report
- March 2021
- 75 Pages
Global
€21145EUR$22,000USD£18,133GBP
- Report
- April 2022
- 120 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Report
- January 2021
- 120 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Report
- August 2022
United States
From €1865EUR$1,940USD£1,599GBP
- Report
- August 2022
Global
From €1144EUR$1,190USD£981GBP
- Report
- August 2021
Global
From €3835EUR$3,990USD£3,289GBP
- Report
- August 2021
Europe
From €3287EUR$3,420USD£2,819GBP
- Report
- February 2021
Global
From €2845EUR$2,960USD£2,440GBP
- Report
- February 2023
- 1359 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Report
- April 2021
- 127 Pages
Global
From €10568EUR$10,995USD£9,062GBP
The Parkinson Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Parkinson's Disease is a progressive neurological disorder that affects movement, and is caused by a lack of dopamine in the brain. Parkinson Drugs are used to treat the symptoms of the disease, and can include levodopa, dopamine agonists, monoamine oxidase inhibitors, and catechol-O-methyltransferase inhibitors. These drugs can help to improve motor function, reduce tremors, and improve quality of life.
The Parkinson Drug market is highly competitive, with many companies offering a range of treatments. Some of the major players in the market include AbbVie, GlaxoSmithKline, Merck, Novartis, Pfizer, and Teva Pharmaceuticals. Show Less Read more